80 related articles for article (PubMed ID: 10850863)
1. Allelic losses in neurofibromatosis 2-associated meningiomas.
Lamszus K; Vahldiek F; Mautner VF; Schichor C; Tonn J; Stavrou D; Fillbrandt R; Westphal M; Kluwe L
J Neuropathol Exp Neurol; 2000 Jun; 59(6):504-12. PubMed ID: 10850863
[TBL] [Abstract][Full Text] [Related]
2. Meningiomas in patients with neurofibromatosis type 2 predominantly comprise 'immunogenic subtype' tumours characterised by macrophage infiltration.
Teranishi Y; Miyawaki S; Nakatochi M; Okano A; Ohara K; Hongo H; Ishigami D; Sakai Y; Shimada D; Takayanagi S; Ikemura M; Komura D; Katoh H; Mitsui J; Morishita S; Ushiku T; Ishikawa S; Nakatomi H; Saito N
Acta Neuropathol Commun; 2023 Sep; 11(1):156. PubMed ID: 37752594
[TBL] [Abstract][Full Text] [Related]
3. Clinical and genomic differences in supratentorial versus infratentorial NF2 mutant meningiomas.
Tabor JK; O'Brien J; Vasandani S; Vetsa S; Lei H; Jalal MI; Marianayagam NJ; Jin L; Millares Chavez M; Haynes J; Dincer A; Yalcin K; Aguilera SM; Omay SB; Mishra-Gorur K; McGuone D; Morales-Valero SF; Fulbright RK; Gunel M; Erson-Omay EZ; Moliterno J
J Neurosurg; 2023 Dec; 139(6):1648-1656. PubMed ID: 37243548
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas.
Barski D; Wolter M; Reifenberger G; Riemenschneider MJ
Brain Pathol; 2010 May; 20(3):623-31. PubMed ID: 19922547
[TBL] [Abstract][Full Text] [Related]
5. Cases of Mixed Schwannoma-Meningioma With and Without Neurofibromatosis 2 with Emphasis on Tumorigenesis.
Rajeswarie RT; Mallik D; Rudrappa S; Gopal S
Int J Surg Pathol; 2024 May; 32(3):511-514. PubMed ID: 37487199
[TBL] [Abstract][Full Text] [Related]
6. Sporadic and neurofibromatosis type 2-associated meningioma in children and adolescents.
Wagener K; Beckhaus J; Boekhoff S; Friedrich C; Müller HL
J Neurooncol; 2023 Jul; 163(3):555-563. PubMed ID: 37402092
[TBL] [Abstract][Full Text] [Related]
7. Somatic AKT1 mutations cause meningiomas colocalizing with a characteristic pattern of cranial hyperostosis.
Keppler-Noreuil KM; Baker EH; Sapp JC; Lindhurst MJ; Biesecker LG
Am J Med Genet A; 2016 Oct; 170(10):2605-10. PubMed ID: 27550858
[TBL] [Abstract][Full Text] [Related]
8. [Meningioma].
Sasaki H
No Shinkei Geka; 2023 Sep; 51(5):829-836. PubMed ID: 37743334
[TBL] [Abstract][Full Text] [Related]
9. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2.
Sarkar S; Throckmorton W; Bingham R; Msaouel P; Genovese G; Slopis J; Rao P; Sadighi Z; Herzog CE
Curr Oncol; 2023 Mar; 30(3):3355-3365. PubMed ID: 36975468
[TBL] [Abstract][Full Text] [Related]
10. NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas.
Rutland JW; Gill CM; Loewenstern J; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Shrivastava RK; Fowkes M
Cancer Immunol Immunother; 2021 Jan; 70(1):169-176. PubMed ID: 32661686
[TBL] [Abstract][Full Text] [Related]
11. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic
Brastianos PK; Twohy EL; Gerstner ER; Kaufmann TJ; Iafrate AJ; Lennerz J; Jeyapalan S; Piccioni DE; Monga V; Fadul CE; Schiff D; Taylor JW; Chowdhary SA; Bettegowda C; Ansstas G; De La Fuente M; Anderson MD; Shonka N; Damek D; Carrillo J; Kunschner-Ronan LJ; Chaudhary R; Jaeckle KA; Senecal FM; Kaley T; Morrison T; Thomas AA; Welch MR; Iwamoto F; Cachia D; Cohen AL; Vora S; Knopp M; Dunn IF; Kumthekar P; Sarkaria J; Geyer S; Carrero XW; Martinez-Lage M; Cahill DP; Brown PD; Giannini C; Santagata S; Barker FG; Galanis E
J Clin Oncol; 2023 Jan; 41(3):618-628. PubMed ID: 36288512
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
Imura T; Mitsuhara T; Horie N
Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
[TBL] [Abstract][Full Text] [Related]
13. Genomic Landscape of Meningiomas.
Wang JZ; Nassiri F; Mawrin C; Zadeh G
Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
[TBL] [Abstract][Full Text] [Related]
14. Loss of SUFU function in familial multiple meningioma.
Aavikko M; Li SP; Saarinen S; Alhopuro P; Kaasinen E; Morgunova E; Li Y; Vesanen K; Smith MJ; Evans DG; Pöyhönen M; Kiuru A; Auvinen A; Aaltonen LA; Taipale J; Vahteristo P
Am J Hum Genet; 2012 Sep; 91(3):520-6. PubMed ID: 22958902
[TBL] [Abstract][Full Text] [Related]
15. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
Ren L; Xie Q; Deng J; Chen J; Yu J; Wang D; Wakimoto H; Gong Y; Hua L
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38552238
[TBL] [Abstract][Full Text] [Related]
16. A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in
Adams CL; Ercolano E; Ferluga S; Sofela A; Dave F; Negroni C; Kurian KM; Hilton DA; Hanemann CO
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070062
[TBL] [Abstract][Full Text] [Related]
17. [Classification and Molecular Diagnosis of Benign Brain Tumors].
Yoshimoto K
No Shinkei Geka; 2023 Sep; 51(5):771-777. PubMed ID: 37743328
[TBL] [Abstract][Full Text] [Related]
18. Atypical meningiomas with an immunohistochemical profile consistent with hypermetabolic or proliferative molecular groups show high mitotic index, chromosomal instability, and higher recurrence risk.
Barresi V; Ammendola S; Simbolo M; Pedron S; Caffo M; Scarpa A
Virchows Arch; 2023 Jul; 483(1):97-104. PubMed ID: 37014425
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.
Chang IB; Cho BM; Moon SM; Park SH; Oh SM; Cho SJ
J Korean Neurosurg Soc; 2010 Jul; 48(1):14-9. PubMed ID: 20717507
[TBL] [Abstract][Full Text] [Related]
20. Uncovering the molecular landscape of meningiomas and the impact of perioperative steroids on patient survival.
Furtak J; Birski M; Bebyn M; Śledzińska P; Krajewski S; Szylberg T; Krystkiewicz K; Przybył J; Zielińska K; Soszyńska K; Majdańska A; Ryfa A; Bogusiewicz J; Bojko B; Harat M
Acta Neurochir (Wien); 2023 Jul; 165(7):1739-1748. PubMed ID: 37067618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
